Analysis of the effectiveness and safety of dexmedetomidine nasal drops for sedation during lumbar puncture in children

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400090399

Enrollment

Unknown

Registered

2024-09-29

Start date

2024-11-01

Completion date

Unknown

Last updated

2024-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Interventions

Experimental group:Dexmedetomidine nasal drops

Control group:None

Eligibility

Sex/Gender

All

Age

2 Years to 6 Years

Inclusion criteria

Inclusion criteria: (1) Age range from 2 to 6 years old; (2) Children who are scheduled to undergo lumbar puncture examination.

Exclusion criteria

Exclusion criteria: (1) Individuals with contraindications for waist wear; (2) Nasal malformation;(3) Dysfunction of important organs such as liver and kidney dysfunction, congenital heart disease, etc; (4) Individuals who have taken psychotropic drugs within 2 months prior to admission; (5) Individuals with intellectual disabilities.

Design outcomes

Primary

Measure	Time frame
Observer's Assessment of Alertness/Sedation;	—

Secondary

Measure	Time frame
Mean arterial pressure;Heart rate;Pain score ;	—

Countries

China

Contacts

Public ContactWu Xin

Zhejiang Hospital Sandun Campus

18055706372@163.com+86 180 5570 6372

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026